✦ LIBER ✦

Lipsome-encapsulated doxorubicin (MYOCET) and cyclophosphamide is superior to epirubicin and cyclophosphamide in first-line therapy of metastatic breast cancer

✍ Scribed by S. Chan; N. Davidson; E. Juozaityte; F. Erdkamp; N. Azarnia; L.W. Lee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial of liposomal doxorubicin

✍ Chan, S. 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 91 KB

Phase III study of liposome-encapsulated

✍ Chan, S.; Davidson, N.; Juozaityte, E.; Erdkamp, F.; Hooftman, L.; Azarnia, N. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Activity of first-line epirubicin and pa

✍ Gennari, A; Bruzzi, P; Orlandini, C; Salvadori, B; Donati, S; Landucci, E; Guarn 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Cyclophosphamide and liposomal-encapsula

✍ Karampeazis⁎, A.; Ardavanis, A.; Kentepozidis, N.; Nikolaou, Ch.; Bozionelou, V. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 80 KB

Gemcitabine, epirubicin and paclitaxel (

✍ T. Brodowicz; S. Beslija; J. Cervek; Z. Mrsic-Krmpotic; I. Tchernozemsky; C. Wil 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB